The commensal Streptococcus salivarius K12 downregulates the innate immune responses of human epithelial cells and promotes host-microbe homeostasis.
Cosseau. Celine C; Devine. Deirdre A DA; Dullaghan. Edie E; Gardy. Jennifer L JL; Chikatamarla. Avinash A; Gellatly. Shaan S; Yu. Lorraine L LL; Pistolic. Jelena J; Falsafi. Reza R; Tagg. John J; Hancock. Robert E W RE
Key Findings
- S. salivarius K12 changes the activity of 565 host genes related to immunity, cell structure, and homeostasis
- It suppresses baseline IL‑8 secretion and blocks IL‑8 spikes caused by LL‑37, Pseudomonas aeruginosa, and flagellin
- The anti‑inflammatory effect coincides with reduced NF‑kappaB pathway activation
Practical Outcomes
- Taking a K12‑containing probiotic may help lower chronic airway or oral inflammation and support a balanced immune response, especially for those using LL‑37 or facing frequent infections. While the data are from cell cultures, they suggest that regular K12 supplementation could be a low‑risk strategy to maintain mucosal health and reduce over‑active inflammatory signaling.
Summary
The study shows that the probiotic bacterium Streptococcus salivarius K12 can calm down inflammation in airway cells by cutting down the release of IL‑8 and other signals, even when the cells are challenged with the antimicrobial peptide LL‑37 or harmful bacteria. It does this by dampening the NF‑kappaB pathway and tweaking many genes linked to cell health and barrier function.
Abstract
Streptococcus salivarius is an early colonizer of human oral and nasopharyngeal epithelia, and strain K12 has reported probiotic effects. An emerging paradigm indicates that commensal bacteria downregulate immune responses through the action on NF-kappaB signaling pathways, but additional mechanisms underlying probiotic actions are not well understood. Our objective here was to identify host genes specifically targeted by K12 by comparing their responses with responses elicited by pathogens and to determine if S. salivarius modulates epithelial cell immune responses. RNA was extracted from human bronchial epithelial cells (16HBE14O- cells) cocultured with K12 or bacterial pathogens. cDNA was hybridized to a human 21K oligonucleotide-based array. Data were analyzed using ArrayPipe, InnateDB, PANTHER, and oPOSSUM. Interleukin 8 (IL-8) and growth-regulated oncogene alpha (Groalpha) secretion were determined by enzyme-linked immunosorbent assay. It was demonstrated that S. salivarius K12 specifically altered the expression of 565 host genes, particularly those involved in multiple innate defense pathways, general epithelial cell function and homeostasis, cytoskeletal remodeling, cell development and migration, and signaling pathways. It inhibited baseline IL-8 secretion and IL-8 responses to LL-37, Pseudomonas aeruginosa, and flagellin in epithelial cells and attenuated Groalpha secretion in response to flagellin. Immunosuppression was coincident with the inhibition of activation of the NF-kappaB pathway. Thus, the commensal and probiotic behaviors of S. salivarius K12 are proposed to be due to the organism (i) eliciting no proinflammatory response, (ii) stimulating an anti-inflammatory response, and (iii) modulating genes associated with adhesion to the epithelial layer and homeostasis. S. salivarius K12 might thereby ensure that it is tolerated by the host and maintained on the epithelial surface while actively protecting the host from inflammation and apoptosis induced by pathogens.
Study Information
pubmed
2008
2008-07-14T00:00:00.000Z
10.1128/iai.00188-08